SCHEMBL4730464

SCHEMBL4730464

COc1ccc2sc3c(sc4c5cc(OC)ccc5sc43)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 5/20 0.53
MAPT P10636 4/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
HSD17B10 Q99714 2/20 0.53
TSHR P16473 1/20 0.53
GFER P55789 1/20 0.53
L3MBTL1 Q9Y468 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
CYP1A2 P05177 1/20 0.49
PPARG P37231 1/20 0.49
NCOA2 Q15596 1/20 0.49
NCOA1 Q15788 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11892118 0.91 KDM4E (0.46) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17040028 0.87 ALDH1A1 (0.66) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL11892334 0.86 ATM (0.44) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL13502296 0.83 KDM4E (0.65) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL10031374 0.79 HTT (0.51) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL18252673 0.78 HTT (0.50) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL10031370 0.77 CYP1A2 (0.48) KDM4EALDH1A1MAPTTSHRL3MBTL1
SCHEMBL10031390 0.77 CYP1A2 (0.48) KDM4EALDH1A1MAPTTSHRL3MBTL1
SCHEMBL12269054 0.77 KDM4E (0.46) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL30120715 0.76 KDM4E (0.83) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724272-B1 CHALCOGEN-CONTAINING FUSED-RING POLYCYCLIC ORGANIC MATERIAL AND PROCESS FOR PRODUCING THE SAME JAPAN SCIENCE & TECH AGENCY (JP) 2013-08-21 EP disclosed
US-20120190868-A1 SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2012-07-26 US disclosed
EP-2452942-A1 SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM Sumitomo Chemical Company, Limited (JP) 2012-05-16 EP disclosed
US-8044218-B2 Chalcogen-containing fused polycyclic organic material and method for producing same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-10-25 US disclosed
US-20070117973-A1 Chalcogen-containing fused polycyclic organic material and method for producing same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190868-A1 SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM EBPL, SAAL1, APOL1 KDM4E 2974/4885ALDH1A1 2070/4885MAPT 4013/4885
US-20070117973-A1 Chalcogen-containing fused polycyclic organic material and method for producing same SLC43A1, OCIAD2, SLC22A8 KDM4E 4643/4885ALDH1A1 4207/4885MAPT 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.